https://www.indianpharmapost.com/glenmark-initiates-multi-country-phase-3-clinical-trial-for-envafolimab-in-resectable-stage-iii-nsclc-177392025-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/poly-medicure-to-acquire-90-stake-in-pendracare-group-for-183-million-177402025-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/jagsonpal-pharmaceuticals-appoints-amrut-medhekar-as-chief-operating-officer-177412025-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/indegene-opens-new-center-in-pune-177422025-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-lifesciences-gets-4-usfda-observations-for-jarod-injectable-facility-177432025-09-06T00:00:00+05:30always0.9